Telix Pharmaceuticals | TLX - Betriebsergebnis

Aktienkurs
15.00
Täglich Wechseln
0 0%
Monatlich
9.81%
Jährlich
-46.41%
Q2 Prognose
14.62




Betriebsergebnis Veränderung Datum
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Mayne Pharma AUD -3.3M 15.67M 2024-06
Medical Developments International AUD -36K 444K 2025-12
Mesoblast USD -30.96M 11.14M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Pacific Edge NZD -19.4M 2.91M 2025-12
Paradigm Biopharmaceuticals AUD -21.57M 13.07M 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 500.3M 37.95M 2025-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12